Psychological Challenges of Adults With Severe Mental Illness During the COVID-19 Pandemic

Kadiatou Diallo-Montford, DrPH, MPH ; Jessica S. Schwind, PhD ; Stacy W. Smallwood, PhD ; Amenah Qotineh, MSc ; Kelly L. Sullivan, PhD

J Clin Psychiatry 2025;86(1):24m15448

Abstract

Background: The COVID-19 pandemic was an unprecedented global health crisis. Vulnerable populations with preexisting mental illness have been disproportionately burdened and may experience adverse mental health outcomes related to the COVID-19 pandemic.

Objectives: Our objective was to evaluate the association between COVID-19 diagnosis, known exposure to COVID-19, sheltering in place, symptom severity, psychological distress, and depression severity among adults with severe mental illness (SMI).

Methods: In a cross-sectional study, participants were recruited among patients with SMI who visited an urban community health center in Georgia between February 1, 2019, and March 11, 2021. Measures included COVID-19 impacts on the symptoms of schizophrenia and other psychotic disorders, and severe mood disorders with psychotic features, depression symptoms, self-reported psychological distress, and social connectedness.

Results: Adults diagnosed with COVID-19 experienced more severe psychological distress (odds ratio [OR] = 2.48, 95% CI, 1.02–6.28) compared to those not diagnosed with COVID-19. After adjusting for sex and age, adults with SMI who sheltered in place during the lockdown experienced higher psychological distress than those who did not (adjusted odds ratio [aOR] = 2.52, 95% CI, 1.02–6.48). Women experienced significantly higher SMI severity (Brief Psychiatric Rating Scale scores [x̄
± SD] for women =56.7 ±24.4 vs men = 48.5± 19.1; [P= .039]) and higher odds of depression (OR = 2.74, 95% CI, 1.22–6.13) during the pandemic than men. Furthermore, adults with SMI with high social support experienced higher psychological distress than those with low social support (aOR = 4.60, 95% CI, 1.82–11.8).

Conclusions: The findings of this study emphasized the need to incorporate infectious disease responses with mental health interventions during a public health crisis.

J Clin Psychiatry 2025;86(1):24m15448

Author affiliations are listed at the end of this article.

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Buy PDF for $40

Please sign in or purchase this PDF for $40.

References (55)

Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in The United States: Results From The 2019 National Survey On Drug Use And Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 2020. Accessed February, 12, 2021. https://www.samhsa.gov/data
National Center for Health Statistics (U.S.). Health, United States, 2016: With Chartbook on Long-Term Trends in Health. 2017. Accessed May 17, 2021.
Hiscott J, Alexandridi M, Muscolini M, et al. The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev. 2020;53:1–9. CrossRef
Hossain MM, Sultana A, Purohit N. Mental health outcomes of quarantine and isolation for infection prevention: a systematic umbrella review of the global evidence. Epidemiol Health. 2020;42:e2020038. PubMed CrossRef
Moore RC, Depp CA, Harvey PD, et al. Assessing the real-time mental health challenges of COVID-19 in individuals with serious mental illnesses: protocol for a quantitative study. JMIR Res Protoc. 2020;9(5):e19203. PubMed CrossRef
Sukut O, Ayhan Balik CH. The impact of COVID-19 pandemic on people with severe mental illness. Perspect Psychiatr Care. 2021;57(2):953–956.
Hossain MM, Tasnim S, Sultana A, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020;9:636. CrossRef
Bo H-X, Li W, Yang Y, et al. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol Med. 2021;51(6):1052–1053. PubMed CrossRef
Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–920. PubMed CrossRef
Czeisler MÉ, Lane RI, Petrosky E, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic—United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1049–1057. PubMed CrossRef
Fisher J, Tran T, Hammarberg K, et al. Quantifying the mental health burden of the most severe Covid-19 restrictions: a natural experiment. J Affect Disord. 2021;293:406–414. PubMed CrossRef
González-Blanco L, Dal Santo F, García-Álvarez L, et al. COVID-19 lockdown in people with severe mental disorders in Spain: do they have a specific psychological reaction compared with other mental disorders and healthy controls?. Schizophr Res. 2020;223:192–198. PubMed CrossRef
Hao F, Tan W, Jiang L, et al. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain Behav Immun. 2020;87:100–106. PubMed CrossRef
Iasevoli F, Fornaro M, D’Urso G, et al. Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy. Psychol Med. 2021;51(6):1054–1056. PubMed CrossRef
Lee JY, Kim YJ, Chung EH, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis. 2017;17(1):498. PubMed CrossRef
Liu X, Lin H, Jiang H, et al. Clinical characteristics of hospitalised patients with schizophrenia who were suspected to have coronavirus disease (COVID-19) in Hubei Province, China. Gen Psychiatr. 2020;33(2):e100222. PubMed CrossRef
Qiu J, Shen B, Zhao M, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr. 2020;33(2):e100213. PubMed CrossRef
Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–627. PubMed CrossRef
Rohde C, Jefsen OH, Norremark B, et al. Psychiatric symptoms related to the COVID-19 pandemic. Acta Neuropsychiatr. 2020;32(5):274–276. CrossRef
Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–427. PubMed CrossRef
Taquet M, Luciano S, Geddes JR, et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID 19 cases in the USA. Lancet Psychiatry. 2021;8(2):130–140. PubMed CrossRef
Vissink CE, van Hell HH, Galenkamp N, et al. The effects of the COVID-19 outbreak and measures in patients with a pre-existing psychiatric diagnosis: a cross-sectional study. J Affect Disord Rep. 2021;4:100102. PubMed CrossRef
Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2021;20(1):124–130. PubMed CrossRef
Yang L, Wu D, Hou Y, et al. Analysis of psychological state and clinical psychological intervention model of patients with COVID-19. J medRxiv. 2020; 20040899. doi:10.1101/2020.03.22.20040899 CrossRef
Krive J, Patel M, Gehm L, et al. The complexity and challenges of the international classification of diseases, ninth revision, clinical modification to international classification of diseases, 10th revision, clinical modification transition in EDs. Am J Emerg Med, 2015;33(5):713–718. PubMed CrossRef
Zhang J, Yang Z, Wang X, et al. The relationship between resilience, anxiety and depression among patients with mild symptoms of COVID-19 in China: a cross sectional study. J Clin Nurs. 2020;29(21–22):4020–4029.
Faul F, Erdfelder E, Buchner A, et al. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160. CrossRef
Culverhouse BA, Martin AR. Forced business closures: executive orders by the governor closing private businesses. GSULR. 2020;37(1):111.
Andersen J, Larsen J, Kørner A, et al. The brief psychiatric rating scale: schizophrenia, reliability and validity studies. Nordic J Psychiatry. 2009;40:135–138. CrossRef
Hofmann AB, Schmid HM, Jabat M, et al. Utility and validity of the brief psychiatric rating scale (BPRS) as a transdiagnostic scale. Psychiatry Res. 2022;314:114659. PubMed CrossRef
Zanello A, Berthoud L, Ventura J, et al. The Brief Psychiatric Rating Scale (version 4.0) factorial structure and its sensitivity in the treatment of outpatients with unipolar depression. Psychiatry Res. 2013;210(2):626–633. PubMed CrossRef
Park S-C, Jang EY, Kim K, et al. Establishing the cut-off scores for the severity ranges of schizophrenia on the BPRS-6 scale: findings from the REAP-AP. Psychiatry Clin Psychopharmacol. 2019;29(4):895–898. CrossRef
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. PubMed CrossRef
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health Questionnaire. JAMA. 1999;282(18):1737–1744. PubMed
Adams DP, Holt JR, Martin JA, et al. The effect of COVID-19 lockdown on PHQ depression screening scores for high school athletes. Int J Environ Res Public Health. 2022;19(16):9943. PubMed CrossRef
Stolk Y, Kaplan I, Szwarc J. Clinical use of the Kessler psychological distress scales with culturally diverse groups. Int J Methods Psychiatr Res. 2014;23(2):161–183. PubMed CrossRef
Kantamneni N. The impact of the COVID-19 pandemic on marginalized populations in the United States: a research agenda. J Vocat Behav. 2020;119:103439. PubMed CrossRef
Lemieux CM, Richards KN, Hunter DR, et al. Interrelationships among physical health, health-related, and psychosocial characteristics of persons receiving integrated care in community mental health settings. J Soc Serv Res. 2015;41(5):561–583. CrossRef
Lee RM, Draper M, Lee SJJ. Social connectedness, dysfunctional interpersonal behaviors, and psychological distress: testing a mediator model. J Couns Psychol. 2001;48(3):310–318. CrossRef
DiMaggio C. SAS for Epidemiologists: Applications and Methods. Springer; 2013.
Lee SW, Yang JM, Moon SY, et al. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study. Lancet Psychiatry. 2020;7(12):1025–1031. PubMed CrossRef
Wolf MS, Serper M, Opsasnick L, et al. Awareness, attitudes, and actions related to COVID-19 among adults with chronic conditions at the onset of the US outbreak: a cross-sectional survey. Ann Intern Med. 2020;173(2):100–109. PubMed CrossRef
Zhong B-L, Luo W, Li H-M, et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey. Int J Biol Sci. 2020;16(10):1745–1752. PubMed CrossRef
Gourovitch M, Goldberg T. Cognitive deficits in schizophrenia: attention, executive functions, memory and language processing. Schizophr a Neuropsychol Perspect. 1996:72–86.
McKenna PJ. Schizophrenia and Related Syndromes. Routledge; 2013.
Fagiolini A, Goracci A. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry. 2009;70(Suppl 3):22–29. PubMed CrossRef
Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42. PubMed
DE Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77. PubMed CrossRef
Bzdok D, Dunbar RIM. The neurobiology of social distance. Trends Cogn Sci. 2020;24(9):717–733. PubMed CrossRef
Cresswell CM, Kuipers L, Power MJ. Social networks and support in long-term psychiatric patients. Psychol Med. 1992;22(4):1019–1026. PubMed CrossRef
Giallonardo V, Sampogna G, Del Vecchio V, et al. The impact of quarantine and physical distancing following COVID-19 on mental health: study protocol of a multicentric Italian population trial. Front Psychiatry. 2020;11:533. PubMed CrossRef
Gao J, Zheng P, Jia Y, et al. Mental health problems and social media exposure during COVID-19 outbreak. PLoS One. 2020;15(4):e0231924. PubMed CrossRef
Neria Y, Sullivan GM. Understanding the mental health effects of indirect exposure to mass trauma through the media. JAMA. 2011;306(12):1374–1375. PubMed CrossRef
Chow JC, Jaffee K, Snowden L. Racial/ethnic disparities in the use of mental health services in poverty areas. Am J Public Health. 2003;93(5):792–797. PubMed CrossRef
McGinty EE, Baller J, Azrin ST, et al. Quality of medical care for persons with serious mental illness: a comprehensive review. Schizophr Res. 2015;165(2–3):227–235. PubMed CrossRef